Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Collectively declared rate

9.049%

Threshold

Crossed upwards

Timeline

Published

25.02.2026

Transaction

16.02.2026

Voting rights breakdown

Voting rights acquired9.049%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 6

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

ZA02-000000000RMU3

Beneficial owner

Helmut Fink

Declared address

Helmut Fink, 6934 Sulzberg, AT

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open